Alexion Pharma (ALXN) Tops Q3 EPS by 11c
Tweet
Share
E-mailGet Alerts ALXN Hot Sheet
Price: $182.01 --0%
Financial Fact:
Research and development: 179.31M
Today's EPS Names:
MFON, SICP, LBAS, More
Financial Fact:
Research and development: 179.31M
Today's EPS Names:
MFON, SICP, LBAS, More
Join SI Premium – FREE
Alexion Pharma (NASDAQ: ALXN) reported Q3 EPS of $1.27, $0.11 better than the analyst estimate of $1.16. Revenue for the quarter came in at $555.1 million versus the consensus estimate of $541.93 million.
For earnings history and earnings-related data on Alexion Pharma (ALXN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bank of America (BAC) Tops Q1 EPS by $0.07, Beats on Revenue
- Microsoft invests $1.5 bln in Abu Dhabi AI firm G42, takes board seat
- PNC Financial Services (PNC) Tops Q1 EPS by 34c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
